| TTM
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
12/31/2021
|
|
|---|---|---|---|---|---|
| Total Revenue
|
27,369.8890 | 18,042.1530 | 5,499.6890 | 5,822.1400 | 2,553.0610 |
|
Cost of Revenue
|
-9,430.6980 | -6,771.5330 | -2,081.5630 | -2,286.4100 | -1,415.2600 |
|
Gross Profit
|
17,939.1910 | 11,270.6200 | 3,418.1260 | 3,535.7300 | 1,137.8010 |
| Selling, General and Administrative Expenses
|
-26,704.7710 | -19,234.5060 | -6,928.9770 | -6,432.9120 | -6,881.9700 |
|
Research and Development Expenses
|
0 | -- | 0 | -5.5000 | 0 |
| Depreciation, Amortization and Depletion
|
-134.5680 | -133.6190 | -137.9580 | -138.3590 | -130.3440 |
| Other Income/Expense, Operating
|
-209.6400 | -57.9040 | -8.0670 | -12.7180 | -21.1520 |
|
Operating Income/Expenses
|
-27,048.9790 | -19,426.0290 | -7,075.0020 | -6,589.4890 | -7,033.4660 |
|
Total Operating Profit/Loss
|
-9,109.7880 | -8,155.4090 | -3,656.8760 | -3,053.7590 | -5,895.6650 |
| Total Net Finance Income/Expense
|
-376.5610 | -257.0760 | -1,570.2530 | -855.0890 | -93.8130 |
| Net Investment Income
|
-- | -- | -- | 0 | -104.7720 |
| Irregular Income/Expenses
|
-- | -- | -- | 0 | -7.3690 |
|
Other Income/Expense, Non-Operating
|
0 | 0 | 480.6100 | 0 | -- |
|
Non-Operating Income/Expenses, Total
|
-376.5610 | -257.0760 | -1,089.6430 | -855.0890 | -205.9540 |
|
Pretax Income
|
-9,486.3490 | -8,412.4850 | -4,746.5190 | -3,908.8480 | -6,101.6190 |
|
Net Income from Continuing Operations
|
-9,486.3490 | -8,412.4850 | -4,746.5190 | -3,908.8480 | -6,101.6190 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-9,486.3490 | -8,412.4850 | -4,746.5190 | -3,908.8480 | -6,101.6190 |
|
Net Income after Non-Controlling/Minority Interests
|
-9,486.3500 | -8,412.4850 | -4,746.5190 | -3,908.8480 | -6,086.8810 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
0 | -- | -- | -- | -- |
|
Net Income Available to Common Stockholders
|
-9,486.3500 | -8,412.4850 | -4,746.5190 | -3,908.8480 | -6,086.8810 |
|
Diluted Net Income Available to Common Stockholders
|
-9,486.3500 | -8,412.4850 | -4,746.5190 | -3,908.8480 | -6,086.8810 |
| Basic EPS
|
-0.09 | -0.09 | -0.18 | -0.25 | -0.40 |
| Diluted EPS
|
-0.09 | -0.09 | -0.18 | -0.25 | -0.42 |
|
Basic Weighted Average Shares Outstanding
|
104,543.0340 | 90,836.0200 | 26,464.0030 | 15,787.9080 | 14,158.5540 |
|
Diluted Weighted Average Shares Outstanding
|
104,543.0340 | 90,836.0200 | 26,464.0030 | 15,787.9080 | 14,473.0710 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-9,109.7880 | -8,155.4090 | -4,129.7100 | -3,406.7590 | -6,007.8060 |
|
EBITDA
|
-8,975.2200 | -8,021.7900 | -3,991.7520 | -3,268.4000 | -5,877.4620 |
|
Normalized EBITDA
|
-8,316.1300 | -7,391.9350 | -2,483.5640 | -2,775.7330 | -4,750.5440 |
|
Normalized Income
|
-8,827.2590 | -7,782.6300 | -3,238.3310 | -3,416.1810 | -4,974.7010 |
12/31/2021 - 1/15/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade